Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Verastem (VSTM) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Verastem (VSTM) over the last 6 years, with Q3 2025 value amounting to -$37000.0.

  • Verastem's Other Non Operating Income rose 5194.81% to -$37000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year decrease of 126458.33%. This contributed to the annual value of -$123000.0 for FY2024, which is 1284.4% down from last year.
  • As of Q3 2025, Verastem's Other Non Operating Income stood at -$37000.0, which was up 5194.81% from -$110000.0 recorded in Q2 2025.
  • In the past 5 years, Verastem's Other Non Operating Income registered a high of $28000.0 during Q1 2022, and its lowest value of -$1.8 million during Q1 2025.
  • Its 4-year average for Other Non Operating Income is -$150642.9, with a median of -$18500.0 in 2023.
  • Data for Verastem's Other Non Operating Income shows a peak YoY increase of 5194.81% (in 2025) and a maximum YoY decrease of 598666.67% (in 2025) over the last 5 years.
  • Quarter analysis of 4 years shows Verastem's Other Non Operating Income stood at -$7000.0 in 2022, then tumbled by 85.71% to -$13000.0 in 2023, then soared by 161.54% to $8000.0 in 2024, then plummeted by 562.5% to -$37000.0 in 2025.
  • Its last three reported values are -$37000.0 in Q3 2025, -$110000.0 for Q2 2025, and -$1.8 million during Q1 2025.